FDA Warning Crushes ExThera Blood Filter Sales
Understand FDA’s warning letter to ExThera over Seraph 100 blood filter violations: unapproved marketing claims, compassionate use failures, and compliance steps for device makers.
Understand FDA’s warning letter to ExThera over Seraph 100 blood filter violations: unapproved marketing claims, compassionate use failures, and compliance steps for device makers.
FDA warning letter analysis of a California seafood processor’s repeat HACCP, sanitation, and allergen violations, outlining legal risks, enforcement, and compliance steps.